KRAS and Hepatic fibrosis: To test our hypothesis that NS3 exerts TGF-β mimetic activity, thereby causing liver fibrosis, we examined whether the anti-NS3 antibody could prevent liver fibrosis in HCV-infected human hepatocyte-transplanted chimeric mice.